Clinical Trial Update: Thiamine as a Renal Protective Agent in Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating thiamine as a renal protective agent in septic shock; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis

Drugs mentioned

• Thiamine (thiamine)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Sepsis, Kidney Injury | Phase 2 | Status: COMPLETED | Results posted: 2023-06-27